Amylyx Pharmaceuticals, Inc.

NASDAQ:AMLX

Biotechnology

Healthcare
$26.20 +0.93%

+$0.14 today

Market cap
$3.37B
Beta
-0.16
P/E (TTM)
-11.3
EPS (TTM)
-$1.36
52W Low $4.80High $18.61

Volume 1.76M

Average 1.21M

Price history

Amylyx Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+93.07%

Period high

$39.66

Period low

$11.38

Latest

$26.20

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
4Nov 12, 2026Nov 12, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
4Oct 7, 2026Oct 7, 2026
4Sep 14, 2026Sep 14, 2026
4Sep 14, 2026Sep 14, 2026
4Sep 14, 2026Sep 14, 2026
4Sep 14, 2026Sep 14, 2026
4Sep 14, 2026Sep 14, 2026
8-KSep 8, 2026Sep 8, 2026
4Sep 2, 2026Sep 2, 2026
4Aug 20, 2026Aug 20, 2026
4Aug 20, 2026Aug 20, 2026

Competitors

Who does Amylyx Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about AMLX's filings, answered from its disclosures.

What is the latest AMLX filing?

The latest filing shown is 4 dated Nov 12, 2026.

How many recent filings does AMLX have?

Intrinsic Alpha currently shows 20 recent filings for AMLX.